Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
1.100
-0.030 (-2.65%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Spero Therapeutics Employees
Spero Therapeutics had 25 employees as of December 31, 2025. The number of employees decreased by 7 or -21.88% compared to the previous year. That makes Spero Therapeutics the 37,724th largest employer in the world and 5,349th in the United States.
Employees
25
Change (1Y)
-7
Growth (1Y)
-21.88%
Revenue / Employee
$1,879,880
Profits / Employee
$295,320
Market Cap
64.06M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 25 | -7 | -21.88% |
| Dec 31, 2024 | 32 | -14 | -30.43% |
| Dec 31, 2023 | 46 | 11 | 31.43% |
| Dec 31, 2022 | 35 | -111 | -76.03% |
| Dec 31, 2021 | 146 | 57 | 64.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| XBiotech | 87 |
| Fortress Biotech | 78 |
| MindWalk Holdings | 77 |
| Verrica Pharmaceuticals | 76 |
| Biomea Fusion | 37 |
| Oncolytics Biotech | 29 |
| Cingulate | 14 |
SPRO News
- 3 days ago - Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference - GlobeNewsWire
- 13 days ago - Russian plague outbreak could boost these under-the-radar pharma stocks - Invezz
- 16 days ago - Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Spero Therapeutics Transcript: H.C. Wainwright 28th Annual Global Investment Conference - Transcripts
- 4 weeks ago - Spero Therapeutics price target raised to $6 from $5 at H.C. Wainwright - TheFly
- 6 weeks ago - Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Spero Therapeutics to Present at H.C. Wainwright 28th Annual Global Investment Conference - GlobeNewsWire
- 7 weeks ago - Spero Therapeutics files $300M mixed securities shelf - TheFly